Longeveron Inc. (LGVN) Financial Statements (2024 and earlier)

Company Profile

Business Address 1951 NW 7TH AVENUE
MIAMI, FL 33136
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

3/31/2024
Q1
12/31/2023
Q4
9/30/2023
Q3
6/30/2023
Q2
3/31/2023
Q1
12/31/2022
Q4
9/30/2022
Q3
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments5,3613,9338,65713,67719,6588,700
Cash and cash equivalents4,9491,9672,7474,98410,503 
Short-term investments4121,9665,9108,6939,1558,700
Receivables111969696436177
Deferred costs      8,742
Other undisclosed current assets3761,0151,5391,0971865,618
Total current assets:5,8485,04410,29214,87020,28023,237
Noncurrent Assets
Operating lease, right-of-use asset1,2211,3011,3791,4561,5311,604
Property, plant and equipment2,5292,5442,7172,8102,9493,064
Intangible assets, net (including goodwill)2,2872,5392,4822,4252,4092,373
Intangible assets, net (excluding goodwill)2,2872,5392,4822,4252,4092,373
Other noncurrent assets193     
Other undisclosed noncurrent assets  197223247244237
Total noncurrent assets:6,2306,5816,8016,9387,1337,278
TOTAL ASSETS:12,07811,62517,09321,80827,41330,515
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities2,7902,3023,0086136501,255
Accounts payable6388291,700  527
Accrued liabilities2,1521,4731,308613650728
Deferred revenue506506496556506 
Debt  5865781,0282,315557
Estimated litigation liability      1,398
Other undisclosed current liabilities593  1,3981,398505
Total current liabilities:3,8893,3944,0823,5954,8693,715
Noncurrent Liabilities
Liabilities, other than long-term debt1,4481,5991,748   
Other liabilities      
Operating lease, liability1,4481,5991,748   
Other undisclosed noncurrent liabilities    1,8952,0412,185
Total noncurrent liabilities:1,4481,5991,7481,8952,0412,185
Total liabilities:5,3374,9935,8305,4906,9105,900
Equity
Equity, attributable to parent, including:6,7416,63211,26316,31820,50324,615
Common stock   6666
Treasury stock, value  (100)(100)(100)(100)(100)
Additional paid in capital91,80085,97684,72984,11683,71283,010
Accumulated other comprehensive income (loss) (309)(335)(299)(357) 
Accumulated deficit(84,984)(78,956)(73,052)(67,420)(62,773)(58,316)
Stockholders' equity note, subscriptions receivable (100)     
Other undisclosed equity, attributable to parent252115151515
Total equity:6,7416,63211,26316,31820,50324,615
TOTAL LIABILITIES AND EQUITY:12,07811,62517,09321,80827,41330,515

Income Statement (P&L) ($ in thousands)

3/31/2024
Q1
12/31/2023
Q4
9/30/2023
Q3
6/30/2023
Q2
3/31/2023
Q1
12/31/2022
Q4
9/30/2022
Q3
Revenues63150217279121265
Other income  558069 (57)
Cost of revenue(65)(96)(124)(203)(176)(173)
Gross profit:(2)549376(55)92
Operating expenses(5,438)(5,215)(5,805)(4,792)(5,186)(5,279)
Operating loss:(5,440)(5,161)(5,712)(4,716)(5,241)(5,187)
Nonoperating income (expense)
(Other Nonoperating Income (Expense))
   69784(57)
Interest and debt expense     (1,397) 
Other undisclosed loss from continuing operations before equity method investments, income taxes (384)     
Loss from continuing operations before income taxes:(5,824)(5,161)(5,712)(4,647)(5,854)(5,244)
Other undisclosed income from continuing operations   80 1,397 
Loss from continuing operations:(5,824)(5,161)(5,632)(4,647)(4,457)(5,244)
Loss before gain (loss) on sale of properties:(5,244)
Net loss:(5,824)(5,161)(5,632)(4,647)(4,457)(5,244)
Other undisclosed net income (loss) attributable to parent (204)55    
Net loss attributable to parent:(6,028)(5,106)(5,632)(4,647)(4,457)(5,244)
Preferred stock dividends and other adjustments (798)    
Net loss available to common stockholders, diluted:(6,028)(5,904)(5,632)(4,647)(4,457)(5,244)

Comprehensive Income ($ in thousands)

3/31/2024
Q1
12/31/2023
Q4
9/30/2023
Q3
6/30/2023
Q2
3/31/2023
Q1
12/31/2022
Q4
9/30/2022
Q3
Net loss:(5,824)(5,161)(5,632)(4,647)(4,457)(5,244)
Comprehensive loss:(5,824)(5,161)(5,632)(4,647)(4,457)(5,244)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(252)81(36)58357 
Comprehensive loss, net of tax, attributable to parent:(6,076)(5,080)(5,668)(4,589)(4,100)(5,244)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: